Fallows, previously Senior Director, Client Services at Applied Clinical Intelligence, sold Oncology CRO services at Novella and Premier, and most recently sold stand-alone services for DMC, DSMB and Stats, to Pharmaceutical, Biotech, Device, CRO clients. Over the last 5 years, he focused on sales, helping companies like Novella grow from 80 employees to a company of 950. Based in Chicago, IL, he has been a mid-west-based Business Development professional in the pharmaceutical industry for over 15 years. Fallows’ solid sales experience, expertise in creating company growth, along with his personal drive, make him an important addition to Pharmatech’s talent this year.
Rob Bohacs, CEO, stated: “Pharmatech is very enthusiastic about the opportunities and mutual growth that Chris Fallows affords us, as an asset. With Chris’ extensive experience and background he is already a valuable member of Pharmatech.”
Pharmatech, headquartered in Denver, Colorado, is a Site Management Organization (SMO) and Contract Research Organization (CRO) with a focus on oncology clinical research. Through an organized network of cancer clinics, the company focuses on advancing the development of products for a broad range of pharmaceutical and biotechnology companies, and promoting the inclusion of clinical trials in the spectrum of patient treatment options.
For more information about Pharmatech, please visit www.pharmatech.com.